Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
106
NMPA:106
Drug Approvals
Chlorpromazine Hydrochloride Tablets
- Product Name
- 盐酸氯丙嗪片
- Approval Number
- 国药准字H21021955
- Approval Date
- Mar 16, 2021
NMPA
Componnd Paracetamol and Diphenhykramine Hydrochloride Tablets
- Product Name
- 复方氨酚苯海拉明片
- Approval Number
- 国药准字H21023182
- Approval Date
- Mar 16, 2021
NMPA
Chlorpromazine Hydrochloride Tablets
- Product Name
- 盐酸氯丙嗪片
- Approval Number
- 国药准字H21021954
- Approval Date
- Mar 16, 2021
NMPA
Pyritinol Hydrochloride Capsules
- Product Name
- 盐酸吡硫醇胶囊
- Approval Number
- 国药准字H21020484
- Approval Date
- Mar 16, 2021
NMPA
Bismuth Subcarbonate Tablets
- Product Name
- 碱式硝酸铋片
- Approval Number
- 国药准字H21023576
- Approval Date
- Mar 16, 2021
NMPA
Compound Mebendazole Tablets
- Product Name
- 复方甲苯咪唑片
- Approval Number
- 国药准字H21020477
- Approval Date
- Mar 16, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 11
- Next
Clinical Trials
No trials found
News
No news found